These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 9973845

  • 21. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype.
    Tarrant KM, Barclay ML, Frampton CM, Gearry RB.
    Am J Gastroenterol; 2008 Dec; 103(12):3082-93. PubMed ID: 19086959
    [Abstract] [Full Text] [Related]

  • 22. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
    Caradonna L, Amati L, Lella P, Jirillo E, Caccavo D.
    Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
    [Abstract] [Full Text] [Related]

  • 23. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission.
    Herrlinger KR, Noftz MK, Dalhoff K, Ludwig D, Stange EF, Fellermann K.
    Am J Gastroenterol; 2002 Feb; 97(2):377-81. PubMed ID: 11866276
    [Abstract] [Full Text] [Related]

  • 24. [Erythema nodosum in hemorrhagic rectocolitis and Crohn's disease].
    Areias E, Garcia e Silva L.
    Ann Dermatol Venereol; 1986 Feb; 113(3):197-206. PubMed ID: 2875686
    [Abstract] [Full Text] [Related]

  • 25. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
    Ott C, Obermeier F, Thieler S, Kemptner D, Bauer A, Schölmerich J, Rogler G, Timmer A.
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
    [Abstract] [Full Text] [Related]

  • 26. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B.
    Dig Dis; 2009 Sep; 27(3):269-77. PubMed ID: 19786751
    [Abstract] [Full Text] [Related]

  • 27. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH, Stempak JM, Xu W, Lan H, Griffiths AM, Greenberg GR, Steinhart AH, Dotan N, Silverberg MS.
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [Abstract] [Full Text] [Related]

  • 28. Pediatric inflammatory bowel disease: is it different?
    Levine A.
    Dig Dis; 2009 Jun; 27(3):212-4. PubMed ID: 19786743
    [Abstract] [Full Text] [Related]

  • 29. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S, Florin TH, Khalil D, Zhang MF, Patel K, Hamilton I, Hart DN.
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [Abstract] [Full Text] [Related]

  • 30. Body composition in patients with inflammatory bowel disease: a population-based study.
    Jahnsen J, Falch JA, Mowinckel P, Aadland E.
    Am J Gastroenterol; 2003 Jul; 98(7):1556-62. PubMed ID: 12873577
    [Abstract] [Full Text] [Related]

  • 31. Previous experience and quiality of life in patients with inflammatory bowel disease during relapse.
    Casellas F, López Vivancos J, Malagela JR.
    Rev Esp Enferm Dig; 2003 Jul; 95(7):476-9, 471-5. PubMed ID: 12952508
    [Abstract] [Full Text] [Related]

  • 32. Clinical characteristics of inflammatory bowel disease in Thailand: a 16 years review.
    Rerknimitr R, Chalapipat O, Kongkam P, Mb PK.
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S129-33. PubMed ID: 16623017
    [Abstract] [Full Text] [Related]

  • 33. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L, Kuiper I, Lamers CB, Verspaget HW.
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [Abstract] [Full Text] [Related]

  • 34. [Smoking and inflammatory bowel disease: an epidemiological case-control study].
    Martins Júnior EV, Araújo IS, Atallah AN, Miszputen SJ.
    Arq Gastroenterol; 1996 Sep; 33(2):74-8. PubMed ID: 9109972
    [Abstract] [Full Text] [Related]

  • 35. Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role.
    Parente F, Cucino C, Bollani S, Imbesi V, Maconi G, Bonetto S, Vago L, Bianchi Porro G.
    Am J Gastroenterol; 2000 Mar; 95(3):705-11. PubMed ID: 10710061
    [Abstract] [Full Text] [Related]

  • 36. Presentation and management outcome of inflammatory bowel disease in Sudan.
    Khalifa SE, Mudawi HM, Fedail SS.
    Trop Gastroenterol; 2005 Mar; 26(4):194-6. PubMed ID: 16737049
    [Abstract] [Full Text] [Related]

  • 37. Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis.
    Aldhous MC, Drummond HE, Anderson N, Baneshi MR, Smith LA, Arnott ID, Satsangi J.
    Am J Gastroenterol; 2007 Mar; 102(3):589-97. PubMed ID: 17338737
    [Abstract] [Full Text] [Related]

  • 38. Epidemiological and clinical features of Spanish patients with Crohn's disease. Spanish Epidemiological and Economic Study Group on Crohn's disease.
    Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1121-7. PubMed ID: 10524641
    [Abstract] [Full Text] [Related]

  • 39. [Inflammatory bowel diseases in children].
    Langholz E, Munkholm P, Krasilnikoff PA, Binder V.
    Ugeskr Laeger; 1998 Sep 21; 160(39):5648-54. PubMed ID: 9771057
    [Abstract] [Full Text] [Related]

  • 40. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
    Mittal RD, Bid HK, Ghoshal UC.
    Scand J Gastroenterol; 2005 Jul 21; 40(7):827-31. PubMed ID: 16109659
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.